USMLE Pathology: Paraneoplastic Syndromes, Ectopic Hormones, Hypercalcemia, Neurologic

What This Is and Why It Matters for USMLE

Paraneoplastic syndromes are a group of rare disorders caused by the immune response to a malignancy. They are high-yield for Step 1 and Step 2 CK, appearing in both basic science and clinical contexts. This topic is crucial for identifying and managing ectopic hormone production, hypercalcemia, and neurologic manifestations in cancer patients.

High-Yield Facts (What You Must Memorize)

• Pathophysiology: Paraneoplastic syndromes occur when the immune system produces antibodies against tumor antigens, leading to cross-reactivity with normal tissues.
• Classic presentation and physical exam findings:
  • Hormonal syndromes: Cushing's syndrome, SIADH, and hypercalcemia of malignancy.
  • Neurologic syndromes: Lambert-Eaton myasthenic syndrome, subacute cerebellar degeneration, and encephalitis.
• Diagnostic approach:
  • Labs: Tumor markers, hormone levels, and electrolyte panels.
  • Imaging: CT scans, MRI, and PET scans.
• First-line treatment and management:
  • Hormonal syndromes: Corticosteroids, hormone antagonists, and surgery.
  • Neurologic syndromes: Immunosuppression, plasmapheresis, and supportive care.
• Red flags, complications, and follow-up:
  • Failure to identify and manage paraneoplastic syndromes can lead to severe morbidity and mortality.

Clinical Pearls & Buzzwords

• Ectopic ACTH syndrome: Associated with small cell lung cancer and adrenocortical carcinoma.
• SIADH: Characterized by hyponatremia, water retention, and hypotension.
• Lambert-Eaton myasthenic syndrome: Associated with small cell lung cancer and thymoma.
• Hypercalcemia of malignancy: Caused by parathyroid hormone-related protein (PTHrP) or vitamin D analogs.

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation.
2. Generate a differential (most likely and must-not-miss):
   • Hormonal syndromes: Cushing's syndrome, SIADH, and hypercalcemia of malignancy.
   • Neurologic syndromes: Lambert-Eaton myasthenic syndrome, subacute cerebellar degeneration, and encephalitis.
3. Order appropriate initial tests:
   • Labs: Tumor markers, hormone levels, and electrolyte panels.
   • Imaging: CT scans, MRI, and PET scans.
4. Interpret results:
   • Correlate lab and imaging findings with clinical presentation.
   • Consider paraneoplastic syndromes in the differential diagnosis.
5. Initiate treatment and monitoring:
   • Hormonal syndromes: Corticosteroids, hormone antagonists, and surgery.
   • Neurologic syndromes: Immunosuppression, plasmapheresis, and supportive care.

Common Mistakes & Exam Traps

• The mistake: Failing to consider paraneoplastic syndromes in the differential diagnosis.
• Why it happens: Misunderstanding the pathophysiology and clinical presentation.
• How to avoid it: Review the high-yield facts and clinical pearls, and consider paraneoplastic syndromes in patients with unexplained symptoms.
• Exam board insight: The examiners may penalize students for failing to consider paraneoplastic syndromes in the differential diagnosis.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology).
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with chest pain..."). Focus on next step in diagnosis or treatment.
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management.

CCS (Step 3) Relevance (If Applicable)

In Step 3 CCS, consider the following strategy:

• Initial orders: Order basic labs, vitals, and imaging to confirm the diagnosis.
• Monitoring and follow-up: Monitor hormone levels, electrolyte panels, and tumor markers to assess response to treatment.
• Common mistakes: Not ordering indicated tests, delaying treatment, and failing to consider paraneoplastic syndromes in the differential diagnosis.

Practice Questions (3-5 single-best-answer)

Question 1: A 45-year-old woman with a history of breast cancer presents with symptoms of hypercalcemia. Which of the following is the most likely cause?

A) Hyperparathyroidism B) Hypercalcemia of malignancy C) Vitamin D deficiency D) Milk-alkali syndrome

Answer: B) Hypercalcemia of malignancy Explanation: The patient's history of breast cancer and symptoms of hypercalcemia suggest hypercalcemia of malignancy, which is caused by parathyroid hormone-related protein (PTHrP) or vitamin D analogs.

Question 2: A 60-year-old man with a history of small cell lung cancer presents with symptoms of Lambert-Eaton myasthenic syndrome. Which of the following is the most appropriate treatment?

A) Corticosteroids B) Immunosuppression C) Plasmapheresis D) Supportive care

Answer: B) Immunosuppression Explanation: Lambert-Eaton myasthenic syndrome is an autoimmune disorder that requires immunosuppression to manage.

Question 3: A 50-year-old woman with a history of ovarian cancer presents with symptoms of SIADH. Which of the following is the most likely cause?

A) SIADH B) Cushing's syndrome C) Hypercalcemia of malignancy D) Hypothyroidism

Answer: A) SIADH Explanation: The patient's history of ovarian cancer and symptoms of SIADH suggest SIADH, which is caused by the inappropriate secretion of antidiuretic hormone (ADH).

Quick Reference Card (60-Second Summary)

• Ectopic ACTH syndrome: Small cell lung cancer and adrenocortical carcinoma.
• SIADH: Hyponatremia, water retention, and hypotension.
• Lambert-Eaton myasthenic syndrome: Small cell lung cancer and thymoma.
• Hypercalcemia of malignancy: PTHrP or vitamin D analogs.
• First-line treatment: Corticosteroids, hormone antagonists, and surgery.

If You Get Stuck on Test Day

• Eliminate obviously wrong answers based on the patient's history and symptoms.
• Use the "next best step" hierarchy to guide your decision-making (least invasive, most specific).
• For Step 3 CCS, order basic labs, vitals, and imaging to confirm the diagnosis, and monitor hormone levels, electrolyte panels, and tumor markers to assess response to treatment.

Related USMLE Topics

• Hormonal syndromes: Connects to Cushing's syndrome, SIADH, and hypercalcemia of malignancy.
• Neurologic syndromes: Connects to Lambert-Eaton myasthenic syndrome, subacute cerebellar degeneration, and encephalitis.
• Immune system disorders: Connects to autoimmune disorders, allergic reactions, and transplant rejection.